FDA information regarding Biosimilars

Posted in Latest News on August 26, 2013.

The FDA has created a pathway for the approval of biosimilar products, but has not yet approved a biological product as biosimilar or interchangeable. There is no date-certain for when these products will be approved—some estimates are three to five years.
The Board of Pharmacy has established a link on its website to the FDA pathway for approval of biosimilar biological products.



More Latest News

Class III Institutional Pharmacies
October 17, 2018

Beginning on October 19, 2018, the Board of Pharmacy will be issuing permits for this new class of pharmacy. Continue reading


Operating Mobile Pharmacies Under The Emergency Order
October 12, 2018

Please Click Here for More Information Regarding: Operating Mobile Pharmacies Under The Emergency Order Continue reading